EXAI vs. LLY

Last updated Jun 4, 2026

EXAI (Exscientia Ltd ADR) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — EXAI in Biotechnology, LLY in Drug Manufacturers - General. At a 0.09 correlation, their price movements are largely independent.

Performance

EXAI vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Exscientia Ltd ADR (EXAI) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

EXAI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

LLY

• 1D: 1.37%
• 1M: 11.64%
• YTD: 0.72%
• 6M: 4.73%
• 1Y: 44.70%
• 3Y*: 35.56%
• 5Y*: 41.13%
• 10Y*: 32.66%

*Multi-year figures are annualized to reflect compound growth (CAGR)

EXAI vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
EXAI Exscientia Ltd ADR	0.00%	0.00%	-24.49%	20.26%	-73.03%	-27.08%
LLY Eli Lilly and Company	0.72%	40.25%	33.30%	60.91%	34.26%	20.70%

Correlation

The correlation between EXAI and LLY is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (All Time) Calculated using the full available price history since Oct 4, 2021	0.09

Fundamentals

Total Revenue (TTM) EXAI : $17.07M LLY : $72.25B
Gross Profit (TTM) EXAI : -$11.56M LLY : $59.75B
EBITDA (TTM) EXAI : -$135.58M LLY : $32.97B

Return for Risk

EXAI vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY

LLY Risk / Return Rank: 72
LLY Sharpe Ratio Rank: 75
LLY Sortino Ratio Rank: 70
LLY Omega Ratio Rank: 71
LLY Calmar Ratio Rank: 73
LLY Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EXAI vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Exscientia Ltd ADR (EXAI) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	EXAI	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.19	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.26	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.09	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.57	—

Drawdowns

Drawdown Indicators

	EXAI	LLY	Difference
Max Drawdown Largest peak-to-trough decline	—	-68.24%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-23.64%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-34.48%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-34.48%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-34.48%	—
Current Drawdown Current decline from peak	—	-4.26%	—
Average Drawdown Average peak-to-trough decline	—	-19.22%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	9.49%	—

Volatility

Volatility by Period

	EXAI	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.16%	—
Volatility (6M) Calculated over the trailing 6-month period	—	26.81%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	37.88%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	32.79%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	30.14%	—

Dividends

EXAI vs. LLY - Dividend Comparison

EXAI has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.60%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EXAI Exscientia Ltd ADR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.60%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Financials

Frequently Asked Questions

Can I hold both EXAI and LLY in my portfolio?

EXAI and LLY have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.